PGY1 Pharmacy Santa Clara, California

The PGY1 Residency Program at Kaiser Permanente, Santa Clara Medical Center follows guidelines set by the American Society of Health-System Pharmacists and provides thorough training in a variety of specialties.

The purpose of the Kaiser Permanente Santa Clara Area Pharmacy Practice Residency Training Program is to build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

In addition, the program is designed to prepare residents to work in a variety of specialty clinical ambulatory care settings and tertiary care level inpatient clinical settings, working in collaboration with medical residents in training at Kaiser Permanente Santa Clara.

Kaiser Permanente Medical Center at Santa Clara

The Kaiser Permanente Medical Center at Santa Clara is a 343-bed facility with satellite medical offices in Campbell, Milpitas, Mountain View, and Skyport. The campus spans 1.5 million square feet and includes a separate 24-bed licensed inpatient psychiatry facility with pharmacy services. The medical center serves over 375,000 Kaiser Foundation Health Plan members in Santa Clara County. The hospital medical services include NICU (tertiary center) and CV ICU (including LVAD insertion). We are also a center of excellence for oncology. Santa Clara has an accredited medical residency program with about 100 residents in internal medicine, OB GYN and podiatry. We are also a major teaching site for Stanford surgical residents.

---

Pharmacy Services

Pharmacists at Kaiser Permanente Santa Clara practice in inpatient, ambulatory care, outpatient, education, and administration settings.

Inpatient pharmacy clinical services include: behavioral health, CV ICU, heart failure/transplant, ICU, oncology, and PICU.

Ambulatory clinical services with collaborative practice protocols include: anticoagulation, asthma/COPD, behavioral health, Care Plus, cardiovascular risk management, chronic pain, drug use management, heart failure, hospice, infectious diseases, Medicare MTM, oncology, and the specialty services (anemia management, osteoporosis, multiple sclerosis, and thyroid cancer).

Santa Clara At A Glance

---

Learning Experiences

Core Experience

• Ambulatory:
  • CV Risk Management
  • Drug Use Management (DrUM)
  • Drug Use Management with Continuing Medical Education (CME)
  • Oncology
• Hospital:
  • Dispensing/Order Verification
  • Heart Failure/Transplant
  • ICU

Elective Experience

• Ambulatory:
  • Anemia Management
  • Anticoagulation
  • Asthma/COPD
  • Behavioral Health
  • Care Plus
  • Chronic Pain Management
  • Heart Failure
  • Hospice & Home Health Services
  • Infectious Diseases: Hepatitis C & HIV
  • Medicare Part D MTM
  • Multiple Sclerosis
  • Osteoporosis
  • Pediatric Specialties
  • Thyroid Cancer
• Hospital:
  • Behavioral Health
  • Oncology
  • Pediatric ICU

Longitudinal Experience

• Administration & Practice Management
• CV Risk Management (Ambulatory)
• Medication Use Evaluation (MUE)
• Precepting Students & Other Learners
• Residency Research Project

---

Requirements for Acceptance

• Graduate of an Accreditation Council for Pharmacy Education (ACPE)-accredited (or ACPE candidate status) school of pharmacy.
• Must be licensed as an Intern Pharmacist in the state of California by the first day of residency program
• Residents who have not obtained a California Pharmacist license by October 1st are subject to suspension until license is obtained. If license is not obtained by December 15th, employment will be subject to termination.
• State Board of Pharmacy Web Link: http://www.pharmacy.ca.gov/
• Candidates must be registered in the National Matching Services, Inc. (NMS).
• Candidates must participate in the ASHP Matching Program.
• Program NMS Code: 118113 and ASHP Program Code: 92850

---

Application Requirements

• Statement of Interest/Letter of Intent
• Curriculum Vitae
• Official Pharmacy School transcripts, sent directly from the applicant’s college or school of pharmacy
• 3 (three) letters of references/recommendations utilizing the form in PhORCAS
• Application Deadline: January 2, 2024

---

Interview Details

• Virtual interviews will be scheduled after applications have been reviewed.
• Click here to link to the Virtual Information Sessions: 
  • November 17th – 11a.m. – 12p.m. PST
  • December 15th – 11a.m. – 12p.m. PST

**This residency agrees that no person at this residency will solicit, accept, or use any ranking-related information from any residency applicant**

Back to all programs